person
Jonas K.
- Country
- Germany
- Department
- -
Research Overview
assignment
30
Clinical Trials ·
- A Phase III, Randomized, Double-Blinded, Placebo-Controlled Study of Tiragolumab, an Anti-Tigit Antibody, in Combination with Atezolizumab Compared with Placebo in Combination with Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer
- Phase 3 Randomized Study of Nivolumab and Ipilimumab with Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer
- Efficacy and Safety of PF-08634404 Plus Combination Therapy Versus Pembrolizumab Plus Combination Therapy in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
location_city
4
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
399
Sites with multiple studies
Has run more than one trial at 399 of 658 partner sites.
Specializations
Advanced Lung Cancer Treatment
The investigator specializes in treating advanced and metastatic non-small cell lung cancer (NSCLC), with particular focus on novel therapeutic approaches for patients with specific genetic mutations.
- KRAS G12C-positive NSCLC management
- RET fusion-positive NSCLC interventions
- Non-squamous NSCLC treatment strategies
Immunotherapy Applications
Expertise in immunotherapeutic approaches for lung cancer treatment, particularly focusing on combination therapies and immune checkpoint inhibitors.
- PD-L1 targeted therapies
- Durvalumab-based treatment protocols
- Novel immunotherapy combinations
Small Cell Lung Cancer Research
Dedicated focus on small cell lung cancer (SCLC) treatment modalities, including innovative therapeutic combinations and management strategies.
- Limited disease SCLC interventions
- Platinum-based therapy combinations
- Radiotherapy integration protocols
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.